February 26, 2013 — Strain imaging for echo is increasingly being recommended to assist in assessing cancer patients at risk for heart disease. Strain Imaging can provide valuable information when monitoring patients for cardiotoxicity resulting from therapies used to treat cancer.
Until now, strain imaging has been research-oriented, cumbersome to use and usually vendor specific. EchoInsight for Cardio Oncology, a vendor-neutral software platform, assists clinicians to quickly and easily integrate strain imaging into the clinical environment program, while improving patient management. The system includes automated processing, rapid serial study comparison, global and regional longitudinal strain and ejection fraction trending with percent change from baseline. It has clear, concise, highly reliable and detailed visual-based reporting to aid patient management. EchoInsight also offers customized integration to customer healthcare IT workflow.
It has a rapid cineloop review and study comparison, simple, efficient endocardial border tracing, intuitive visualization and analysis and one-click wall motion assessment based on recognized standards. It can automatically calculate ejection fractions, volumes, cardiac output and stroke volume. The system also highlights regions of interest based on user established thresholds.
The company will show the product during the American College of Cardiology (ACC) annual meeting March 9-11, 2013.
For more information: epsilon-imaging.com/echoinsight